Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Columbus at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
The primary purpose of the study is to evaluate the antitumor activity and safety of novel immunotherapy combinations compared with dostarlimab in participants with Programmed death ligand 1 (PD-L1) positive Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC).
Sponsor: GlaxoSmithKline
Check if you qualify for this head and neck cancer clinical trial in Columbus, OH
If you're searching for head and neck cancer treatment options in Columbus, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.